Down 62% in 1 Year, Is This Marijuana Stock Doomed?

Green Organic Dutchman Holdings Ltd (TSX:TGOD) is now fairly priced based on its tangible assets and future sales potential.

Businessmen teamwork brainstorming meeting.

Image source: Getty Images

Investors in Green Organic Dutchman Holdings Ltd (TSX:TGOD) have lost nearly two-thirds of their investment since September of last year. The company is the latest in a long line of cannabis producers that have seen their market value erode as the nascent sector matures. 

But is the recent plunge a sign that the growth story is over or an indication of undervaluation ripe for contrarian investors? Here’s a closer look.

Premiumization strategy

Green Organic Dutchman is betting that people’s preference for quality and organic sources in food also applies to the nascent market for legal marijuana.

Once the industry matures, producers will have to differentiate themselves by access, price, or quality, just like any other consumer industry.

With this in mind, management has picked quality over quantity and has elected to focus on only certified organic products for the Green Organic Dutchman brand. This means their average selling price is $12.22 per gram of organic marijuana, as compared to $9.20 per gram for the ordinary variety. That represents a 32.8% premium. 

However, the higher selling price also entails higher production costs. The best way to measure the company’s premiumization strategy is to monitor the gross margin, which is currently at 48%, as the legal cannabis industry completes a full year of sales and the market matures.   

Fundamentals

Similar to other marijuana companies, Green Organic Dutchman doesn’t have much of a track record to base valuations or estimates on. Instead, let’s take the management’s forecast at face value and judge the company based on potential future revenue. 

According to the company’s investor presentation, the production run rate could hit 200,000 kilogram annually by the fourth quarter of 2020.

Assuming the company produces exactly 200,000 kilograms over the course of 2021 and sells the product at an average price of $12.22 per gram as described above, the company’s annual sales could exceed $2.4 billion by that year. 

The company’s production is already spread far beyond Canada, with pilot facilities in Jamaica, Mexico, Poland, and Denmark, so reaching over $2 billion in annual sales is certainly a possibility. 

At present, the company’s market value hovers around $850 million, which may be justified given the spike in sales expected over the next two years. 

Investors should also consider the fact that Green Organic Dutchman reported $174.5 million in cash and cash equivalents and $157 million in property, plant, and equipment assets.

Combined, these tangible assets contribute nearly 40% of the company’s current market value. Reported book value represents 50% of market capitalization. 

In other words, Green Organic Dutchman’s valuation isn’t as overblown as some of its peers. 

Bottom line

By focusing on a premiumization strategy and swiftly expanding production to foreign countries, Green Organic Dutchman has positioned itself as a diversified and robust money-maker in an intensely competitive and nascent industry.

While valuations in the marijuana industry are often a game of blind guesses, I believe this company’s current stock price is justified by its future sales potential, higher margins, wider geographic distribution, and underlying tangible assets like cash and property.

The Dutchman is far from doomed.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. 

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »